(Q40219136)

18 September 2017

title

Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer (English)

1 reference

18 September 2017

1 reference

Maricarmen D Planas-Silva

1

1 reference

18 September 2017

Richard D Bruggeman

2

1 reference

18 September 2017

Ronald T Grenko

3

1 reference

18 September 2017

J S Smith

4

1 reference

18 September 2017

publication date

13 October 2006

1 reference

Experimental and Molecular Pathology

18 September 2017

published in

1 reference

18 September 2017

volume

82

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

85-90

1 reference

Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

The Bcl2 family: regulators of the cellular life-or-death switch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Promoting apoptosis as a strategy for cancer drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Of mice and Myc: c-Myc and mammary tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

7 January 2021

c-Myc in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Cancer therapeutics: targeting the dark side of Myc.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Bcl-2 gene family and related proteins in mammary gland involution and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.09.001

10.1016/J.YEXMP.2006.09.001

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference